Product Information
Darunavir-D9 is a prodrug of darunavir, which is an HIV protease inhibitor. Darunavir-D9 has been shown to be bioequivalent in pharmacokinetic parameters to darunavir given as a tablet. The drug exhibits a low plasma concentration profile and high clearance values. This may be due to rapid absorption and distribution of the drug, with a short elimination half-life. Darunavir-D9 also has little effect on the matrix effect and reproducibility of the reaction monitoring assay, making it an ideal candidate for use in clinical trials.
Chemical properties
Technical inquiry about: 3D-IVB37837 Darunavir-D9
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.